AG真人官方

eHealth, Inc. (EHTH) filed an 8-K announcing a planned CEO transition. Current CEO Fran Soistman will step down immediately prior to a Board meeting on 18 Sep 2025 and remain as executive advisor through 31 Dec 2025. The Board has appointed Derrick Duke, 58, former CEO of Magellan Health and ex-CFO/COO of HealthMarkets, as successor CEO and principal executive officer. Duke joins 4 Aug 2025 to begin hand-off; Board membership is expected to follow.

Duke鈥檚 offer letter provides: (i) $700 k annual base salary, (ii) 120 % target annual bonus, (iii) $600 k sign-on bonus (claw-back if he leaves within one year), (iv) 300 k time-based RSUs vesting over three years and 300 k performance-based RSUs tied to a three-year program. A severance agreement grants 24 months鈥� salary, prorated bonus, up to 18 months鈥� COBRA and partial or full equity acceleration upon a 鈥渜ualifying termination,鈥� with enhanced cash (24 mo. salary + 200 % target bonus) and full vesting if termination occurs within a year after a change-in-control. A press release (Ex. 99.1) was furnished on 29 Jul 2025.

The Form 4 filing discloses that Michelle M. Barbeau, Chief Revenue Officer of eHealth, Inc. (EHTH), had 323 common shares withheld on 07/10/2025 to cover tax obligations associated with equity compensation (transaction code F). The shares were valued at $4.14 per share, an aggregate value of roughly $1,337. Following the withholding, Barbeau continues to hold 262,160 shares of eHealth common stock in direct ownership. No derivative securities were involved and no additional purchases or sales were reported. The transaction represents a routine administrative adjustment rather than an active investment decision, and does not materially change insider ownership levels.

ON24, Inc. (NYSE: ONTF) 鈥� Form 144 filing: The notice discloses that insider Sharat Sharan intends to sell 37,784 common shares through Morgan Stanley Smith Barney on or after 14 July 2025. At the reference price used in the form, the proposed sale is valued at $193,454.08. The shares represent roughly 0.09 % of ON24鈥檚 42,475,166 shares outstanding, indicating limited dilution or voting-power impact.

The filing also details insider activity over the prior three months. Sharan has already disposed of 174,793 shares in six separate transactions between 16 April and 30 June 2025, generating about $916,839 in gross proceeds. Most of those sales were executed under Rule 10b5-1 trading plans, suggesting they were pre-scheduled.

Key takeaways for investors:

• The upcoming transaction continues a pattern of insider selling, which can be interpreted as a signal of management鈥檚 near-term sentiment but does not necessarily reflect company fundamentals.
• Because the cumulative sales are small relative to total shares outstanding, direct market-supply pressure is likely minimal.
• The filer affirms no possession of undisclosed adverse information, a standard certification in Form 144.

NewAmsterdam Pharma Company N.V. (ticker NAMSW) has filed a Form 144 indicating that affiliate NAP PoolCo B.V. intends to sell up to 1,433,193 ordinary shares through UBS Financial Services on or after 14 July 2025. Based on the filing鈥檚 stated market value of $30.9 million, the proposed sale represents roughly 1.3 % of the company鈥檚 112.3 million shares outstanding, potentially expanding the public float.

The notice also discloses that the same seller disposed of 303,197 shares on 16 June 2025 for gross proceeds of $5.9 million. No additional information regarding 10b5-1 plans, pricing discounts or company performance was provided. Form 144 is a standard regulatory requirement for affiliates; however, the magnitude of the sale could create short-term share-price pressure and may signal insider monetisation.

eHealth CEO Francis S. Soistman Jr. reported a tax-related share withholding transaction on June 22, 2025. The Form 4 filing discloses the disposition of 1,709 shares of Common Stock at a price of $4.00 per share to satisfy tax withholding obligations.

Following the transaction, Soistman maintains direct beneficial ownership of 780,839 shares of eHealth Common Stock. The transaction was executed under transaction code 'F', indicating a payment of exercise price or tax withholding by delivering or withholding securities.

The reporting person serves as both Director and Chief Executive Officer of eHealth. The transaction was reported within the required filing deadline, with the Form 4 being filed on June 24, 2025, through an attorney-in-fact.

eHealth (Nasdaq:EHTH) filed an 8-K disclosing two material governance items: an extension of Chief Executive Officer Fran Soistman鈥檚 tenure and the 2025 Annual Meeting voting results.

CEO Transition. The board has not yet appointed a successor, so Mr. Soistman will continue as CEO until the earlier of a successor鈥檚 start date or 30 Sep 2025 and then serve as executive advisor through 31 Dec 2025. In exchange, he will receive (i) a $1.0 million retention cash award payable on the first payroll date in Jan 2026, conditioned on service through the transition period, and (ii) an annual performance-based cash bonus tied to the 2025 executive bonus metrics. He will continue to draw his current base salary and vesting will proceed under existing equity awards; no severance will be owed when he relinquishes the CEO title.

Shareholder votes. Of the 34.5 million votes eligible, 72.3 % were represented. Stockholders re-elected three Class I directors, ratified Ernst & Young LLP, and approved the 2025 advisory say-on-pay. They also approved an amendment to the 2024 Equity Incentive Plan to add 1.5 million shares (鈮�5 % of outstanding common stock), expanding the company鈥檚 capacity to grant equity awards.

The filing enhances leadership stability but increases executive compensation expense and introduces potential dilution from the larger share pool.

eHealth (EHTH) Director Prama Bhatt received an annual equity grant of 34,574 restricted stock units (RSUs) on June 17, 2025, as part of the company's non-employee director compensation program. The RSUs were granted at $0 cost and increased Bhatt's total beneficial ownership to 79,438 shares.

Key terms of the RSU grant:

• Vesting occurs in four equal quarterly installments starting June 17, 2025
• Full vesting acceleration triggers: - Day before next annual stockholder meeting - Upon Change in Control
• Vesting contingent on continued service as defined in the 2024 Equity Incentive Plan

This Form 4 filing was submitted by attorney-in-fact Sonwha Lee on June 20, 2025, within the required reporting timeline for insider transactions.

eHealth (EHTH) Director Andrea C. Brimmer received a significant equity grant on June 17, 2025, consisting of 34,574 restricted stock units (RSUs) as part of the company's annual non-employee director compensation program. Following this transaction, Brimmer's total direct holdings increased to 118,481 shares.

Key terms of the RSU grant:

• RSUs vest quarterly over one year in four equal installments starting June 17, 2025
• Accelerated vesting triggers include: - Day before next annual stockholder meeting - Change in control event
• Vesting contingent on continued service as defined in 2024 Equity Incentive Plan
• Each RSU converts to one common share upon vesting
• Grant price recorded at $0